FDA Approves First Alzheimer’s Blood Test For Americans As Young As 40
The FDA has cleared the first Alzheimer’s blood test for symptomatic patients as young as 40. The test measures amyloid and tau biomarkers from a single blood draw and identified positive biomarkers with 97.6% accuracy in a validation study. New Atlas reports: PrecivityAD2 is a single blood test that quickly assesses the proteins am … ⌘ Read more